Your browser doesn't support javascript.
loading
Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection.
Ambrosius, Björn; Pitarokoili, Kalliopi; Schrewe, Lisa; Pedreiturria, Xiomara; Motte, Jeremias; Gold, Ralf.
Affiliation
  • Ambrosius B; Department of Neurology, St. Josef Hospital, Ruhr-University, Bochum, Germany. Bjoern.Ambrosius@ruhr-uni-bochum.de.
  • Pitarokoili K; Department of Neurology, St. Josef Hospital, Ruhr-University, Bochum, Germany.
  • Schrewe L; Department of Neurology, St. Josef Hospital, Ruhr-University, Bochum, Germany.
  • Pedreiturria X; Current address: Department of Neurology, University Hospital Bern, University of Bern, Bern, Switzerland.
  • Motte J; Department of Neurology, St. Josef Hospital, Ruhr-University, Bochum, Germany.
  • Gold R; Department of Neurology, St. Josef Hospital, Ruhr-University, Bochum, Germany.
J Neuroinflammation ; 14(1): 92, 2017 04 26.
Article in En | MEDLINE | ID: mdl-28446186

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schwann Cells / Axons / Fingolimod Hydrochloride / Neuroprotection / Immunosuppressive Agents / Neuritis, Autoimmune, Experimental Limits: Animals Language: En Journal: J Neuroinflammation Journal subject: NEUROLOGIA Year: 2017 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schwann Cells / Axons / Fingolimod Hydrochloride / Neuroprotection / Immunosuppressive Agents / Neuritis, Autoimmune, Experimental Limits: Animals Language: En Journal: J Neuroinflammation Journal subject: NEUROLOGIA Year: 2017 Document type: Article Affiliation country: Country of publication: